NasdaqGS:BCRXBiotechs
BioCryst Uses Equity Grants To Support Rare Disease Pipeline And Talent
BioCryst Pharmaceuticals (NasdaqGS:BCRX) granted inducement stock options and restricted stock units to 24 newly hired employees.
The equity awards are part of the company’s talent acquisition and retention program and were approved in connection with these hires.
BioCryst focuses on treatments for rare diseases and infectious conditions, areas that often require specialized expertise and long development cycles. Bringing in 24 new employees with equity incentives indicates that the company...